{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:30:03Z","timestamp":1792114203677,"version":"4.4.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbi.2025.106237","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:15:23Z","timestamp":1766247323000},"page":"106237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["From gut to glee: Is butyrate a promising antidepressant? A systematic review and mechanistic insights"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-6345","authenticated-orcid":false,"given":"Vera","family":"Korenblik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia K.M.","family":"Schilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilke G.S.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost G.","family":"Daams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudi L.H.","family":"Bockting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Brul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-3331","authenticated-orcid":false,"given":"Aniko","family":"Korosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.106237_b0005","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022 Feb 1;9(2):137\u201350.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"issue":"5","key":"10.1016\/j.bbi.2025.106237_b0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra1201534","article-title":"Measuring the Global Burden of Disease","volume":"369","author":"Murray","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2025.106237_b0015","doi-asserted-by":"crossref","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, et al. The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). Pharmacoeconomics [Internet]. 2021;39(6):653\u201365. Available from: https:\/\/doi.org\/10.1007\/s40273-021-01019-4.","DOI":"10.1007\/s40273-021-01019-4"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"SUPPL. 6","key":"10.1016\/j.bbi.2025.106237_b0025","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106237_b0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/da.20262","article-title":"Role of GABA in anxiety and depression","volume":"24","author":"Kalueff","year":"2007","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/mp.2014.163","article-title":"The organization of the stress system and its dysregulation in depressive illness","volume":"20","author":"Gold","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2025.106237_b0045","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1176\/appi.ajp.2021.20121776","article-title":"Association between systemic inflammation and individual symptoms of depression: a pooled analysis of 15 population-based cohort studies","volume":"178","author":"Frank","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106237_b0050","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.159.8.1354","article-title":"Article Remission in Major Depressive Disorder: a Comparison of Pharmacotherapy, Psychotherapy, and Control Conditions","volume":"Vol. 159","author":"Casacalenda","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106237_b0055","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0447.2009.01519.x","article-title":"Prevalence and predictors of recurrence of major depressive disorder in the adult population","volume":"122","author":"Hardeveld","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.bbi.2025.106237_b0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0029665117002026","article-title":"Nutritional psychiatry: the present state of the evidence","volume":"76","author":"Marx","year":"2017","journal-title":"Proc. Nutr. Soc."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s13668-025-00619-2","article-title":"Gut Microbiome, Diet and Depression: Literature Review of Microbiological, Nutritional and Neuroscientific Aspects","volume":"14","author":"Clerici","year":"2025","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.bbi.2025.106237_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2020.01.102","article-title":"Gut microbiota and major depressive disorder: a systematic review and meta-analysis","volume":"266","author":"Sanada","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-023-02670-5","article-title":"Gut microbiota composition in depressive disorder: a systematic review, meta-analysis, and meta-regression","volume":"13","author":"Gao","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106237_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34504-1","article-title":"The gut microbiota and depressive symptoms across ethnic groups","author":"Bosch","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2025.106237_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34502-3","article-title":"Gut microbiome-wide association study of depressive symptoms","author":"Radjabzadeh","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu032","article-title":"Antidepressant-like effect of sodium butyrate is associated with an increase in tet1 and in 5-hydroxymethylation levels in the BDNF gene","volume":"18","author":"Wei","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.bbi.2025.106237_b0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1515\/revneuro-2017-0072","article-title":"Gut microbiome and depression: what we know and what we need to know","volume":"29","author":"Winter","year":"2018","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbi.2025.106237_b0095","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.bbi.2025.106237_b0100","doi-asserted-by":"crossref","unstructured":"Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Vol. 99, Neurochemistry International. Elsevier Ltd; 2016. p. 110\u201332.","DOI":"10.1016\/j.neuint.2016.06.011"},{"key":"10.1016\/j.bbi.2025.106237_b0105","doi-asserted-by":"crossref","unstructured":"Zhang Q, Chen B, Zhang J, Dong J, Ma J, Zhang Y, et al. Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis. BMC Psychiatry [Internet]. 2023;23(1):1\u201315. Available from: https:\/\/doi.org\/10.1186\/s12888-023-04963-x.","DOI":"10.1186\/s12888-023-04963-x"},{"issue":"7","key":"10.1016\/j.bbi.2025.106237_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12072041","article-title":"Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: a randomised controlled pilot study","volume":"12","author":"Palacios","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2025.106237_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-021-02415-8","article-title":"Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes","author":"McMurdie","year":"2022","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bbi.2025.106237_b0120","doi-asserted-by":"crossref","unstructured":"Schneider SM, Girard-Pipau F, Filippi J, H\u00e9buterne X, Moyse D, Calle Hinojosa G, et al. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol [Internet]. 2005;11(39):6165\u20139. Available from: www.wjgnet.com.","DOI":"10.3748\/wjg.v11.i39.6165"},{"issue":"19","key":"10.1016\/j.bbi.2025.106237_b0125","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1128\/AEM.01753-16","article-title":"Consumption of a bifidobacterium bifidum strain for 4 weeks modulates dominant intestinal bacterial taxa and fecal butyrate in healthy adults","volume":"82","author":"Gargari","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"issue":"11","key":"10.1016\/j.bbi.2025.106237_b0130","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3945\/jn.114.197723","article-title":"Modulation of fecal clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults","volume":"144","author":"Ferrario","year":"2014","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbi.2025.106237_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081859","article-title":"Health benefits of lactobacillus gasseri cp2305 tablets in young adults exposed to chronic stress: a randomized, double-blind, placebo-controlled study","author":"Nishida","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0140","article-title":"Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2\u20135-year-old children","volume":"28","author":"Hemalatha","year":"2017","journal-title":"Microb. Ecol. Health Dis."},{"key":"10.1016\/j.bbi.2025.106237_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-020-0127-0","article-title":"Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose\u2013response effects on glucose metabolism in human subjects with metabolic syndrome","author":"Gilijamse","year":"2020","journal-title":"npj Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0150","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2347715","article-title":"Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic","volume":"16","author":"Martin","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbi.2025.106237_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12080770","article-title":"The PROVIT Study\u2014Effects of Multispecies Probiotic Add-on Treatment on Metabolomics in Major Depressive Disorder\u2014A Randomized, Placebo-Controlled Trial","author":"Kreuzer","year":"2022","journal-title":"Metabolites"},{"issue":"129","key":"10.1016\/j.bbi.2025.106237_b0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbi.2025.06.002","article-title":"Add-on probiotics for inflammatory depression \u2013 a double-blind randomized placebo-controlled trial","volume":"1","author":"S\u00f6derberg Veib\u00e4ck","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.bbi.2025.106237_b0165","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jamapsychiatry.2021.2573","article-title":"Perturbations in Gut Microbiota Composition in Psychiatric Disorders: a Review and Meta-analysis","volume":"78","author":"Nikolova","year":"2021","journal-title":"JAMA Psychiat."},{"issue":"7","key":"10.1016\/j.bbi.2025.106237_b0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/PSY.0000000000000965","article-title":"Fecal Short-Chain Fatty Acid Ratios as Related to Gastrointestinal and Depressive Symptoms in Young adults","volume":"83","author":"M\u00fcller","year":"2021","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2025.106237_b0175","first-page":"48","article-title":"Circulating short chain fatty acids are associated with depression severity and predict remission from major depressive disorder","volume":"1","author":"Schiweck","year":"2025","journal-title":"Brain Behav Immun Health."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/YCO.0000000000000758","article-title":"Microbiota-targeted interventions for mental health","volume":"35","author":"Berding","year":"2022","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106237_b0185","first-page":"2021","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"The BMJ."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Method."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"issue":"6","key":"10.1016\/j.bbi.2025.106237_b0200","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbi.2025.106237_b0205","doi-asserted-by":"crossref","unstructured":"Molendijk ML, de Kloet ER. Coping with the forced swim stressor: Current state-of-the-art. Behavioural Brain Research [Internet]. 2019;364(January):1\u201310. Available from: https:\/\/doi.org\/10.1016\/j.bbr.2019.02.005.","DOI":"10.1016\/j.bbr.2019.02.005"},{"issue":"5","key":"10.1016\/j.bbi.2025.106237_b0210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bbi.2025.106237_b0215","doi-asserted-by":"crossref","unstructured":"Bedford A, Gong J. Implications of butyrate and its derivatives for gut health and animal production. Animal Nutrition [Internet]. 2018;4(2):151\u20139. Available from: https:\/\/doi.org\/10.1016\/j.aninu.2017.08.010.","DOI":"10.1016\/j.aninu.2017.08.010"},{"issue":"SUPPL. 1","key":"10.1016\/j.bbi.2025.106237_b0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","article-title":"Comorbidity of mood and anxiety disorders","volume":"12","author":"Kaufman","year":"2000","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.bbi.2025.106237_b0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ddmod.2006.11.003","article-title":"Animal models of depression","volume":"3","author":"Deussing","year":"2006","journal-title":"Drug Discov Today Dis Models."},{"key":"10.1016\/j.bbi.2025.106237_b0230","first-page":"290","article-title":"Efficacy of paeoniflorin on models of depression: a systematic review and meta-analysis of rodent studies","volume":"23","author":"Le","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbi.2025.106237_b0235","first-page":"131","article-title":"Colonic butyrate administration modulates fear memory but not the acute stress response in men: a randomized, triple-blind, placebo-controlled trial","volume":"20","author":"Dalile","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0240","doi-asserted-by":"crossref","DOI":"10.1155\/jnme\/3165876","article-title":"Effects of Short Chain Fatty Acid-Butyrate Supplementation on the Disease Severity, Inflammation, and Psychological Factors in patients with active Ulcerative Colitis: a Double-Blind Randomized Controlled Trial","volume":"2025","author":"Firoozi","year":"2025","journal-title":"J Nutr Metab."},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1348\/014466505X29657","article-title":"The short-form version of the Depression anxiety stress scales (DASS-21): Construct validity and normative data in a large non-clinical sample","volume":"44","author":"Henry","year":"2005","journal-title":"Br. J. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0250","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1037\/pas0000326","article-title":"Psychometric properties of the Leiden Index of Depression Sensitivity (LEIDS)","volume":"29","author":"Solis","year":"2017","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.bbi.2025.106237_b0255","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Vol. 67, Acta psychiatr. scand. 1983.","DOI":"10.1037\/t03589-000"},{"key":"10.1016\/j.bbi.2025.106237_b0260","series-title":"Manual of the General Health Questionnaire","author":"Goldberg","year":"1978"},{"key":"10.1016\/j.bbi.2025.106237_b0265","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-108423","article-title":"Feasibility and acceptability of 8-week oral tributyrin supplementation as add on to antidepressant medication in patients with depression: a study protocol paper for a pilot, randomised controlled trial","author":"Korenblik","year":"2025","journal-title":"BMJ Open [internet]."},{"key":"10.1016\/j.bbi.2025.106237_b0270","first-page":"223","article-title":"Dietary delivery of acetate to the colon using acylated starches as a carrier exerts anxiolytic effects in mice","volume":"1","author":"Kimura-Todani","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2025.106237_b0275","first-page":"12","article-title":"Consumption of Butylated Starch Alleviates the Chronic Restraint Stress-Induced Neurobehavioral and Gut Barrier Deficits through Reshaping the Gut Microbiota","volume":"17","author":"Tian","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2025.106237_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0158950","article-title":"Putative epigenetic involvement of the endocannabinoid system in anxiety- and depression-related behaviors caused by nicotine as a stressor","volume":"11","author":"Hayase","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2025.106237_b0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbr.2011.03.033","article-title":"Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats","volume":"221","author":"Reolon","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.bbi.2025.106237_b0290","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FBP.0b013e32836546fc","article-title":"Effects of sodium butyrate in animal models of mania and depression: Implications as a new mood stabilizer","volume":"24","author":"Resende","year":"2013","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2025.106237_b0300","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/15622975.2011.585663","article-title":"Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus","volume":"13","author":"Yamawaki","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2025.106237_b0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nn1659","article-title":"Sustained hippocampal chromagin reglation in a mouse model of depression and antidepressant action","volume":"9","author":"Tsankova","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"1680","key":"10.1016\/j.bbi.2025.106237_b0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2017.12.004","article-title":"Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice","volume":"1","author":"Yamawaki","year":"2018","journal-title":"Brain Res."},{"issue":"9\u201310","key":"10.1016\/j.bbi.2025.106237_b0320","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000505132","article-title":"Lipopolysaccharide-Induced Depression-like Behaviors is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative stress","volume":"105","author":"Qiu","year":"2020","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2009.04.008","article-title":"Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety","volume":"57","author":"Gundersen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2025.106237_b0330","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2014.02.017","article-title":"Possible additional antidepressant-like mechanism of sodium butyrate: Targeting the hippocampus","volume":"81","author":"Han","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.bbi.2025.106237_b0335","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/0115672026277345240115101852","article-title":"Antidepressant effect of Sodium Butyrate is Accompanied by Brain Epigenetic Modulation in Rats Subjected to Early or late Life stress","volume":"20","author":"Valvassori","year":"2024","journal-title":"Curr. Neurovasc. Res."},{"issue":"76","key":"10.1016\/j.bbi.2025.106237_b0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpsychires.2016.02.008","article-title":"Epigenetic regulation of BDNF in the learned helplessness-induced animal model of depression","volume":"1","author":"Su","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.106237_b0345","doi-asserted-by":"crossref","unstructured":"Valvassori SS, Bitencourt Varela R, Arent CO, Colombo Dal-Pont G, Sarate Bobsin T, Budni J, et al. Sodium Butyrate Functions as an Antidepressant and Improves Cognition with Enhanced Neurotrophic Expression in Models of Maternal Deprivation and Chronic Mild Stress. 2014.","DOI":"10.2174\/1567202611666140829162158"},{"issue":"4","key":"10.1016\/j.bbi.2025.106237_b0350","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1567202612666150728121121","article-title":"Sodium Butyrate, a Histone Deacetylase Inhibitor, Reverses Behavioral and Mitochondrial Alterations in Animal Models of Depression Induced by Early- or Late-life stress","volume":"12","author":"Valvassori","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0355","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2008.08.039","article-title":"Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: Involvement of 5-HT1A receptors","volume":"196","author":"Zhu","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"618","key":"10.1016\/j.bbi.2025.106237_b0360","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2016.03.003","article-title":"Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress","volume":"8","author":"Sun","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2025.106237_b0365","first-page":"391","article-title":"Prebiotics chronotherapy alleviates depression-like behaviors in FMT mice through enhancing short-chain fatty acids receptors and intestinal barrier","volume":"15","author":"Li","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.106237_b0370","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06950-0","article-title":"Butyric acid and valeric acid attenuate stress-induced ferroptosis and depressive-like behaviors by suppressing hippocampal neuroinflammation","author":"Ma","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbi.2025.106237_b0375","first-page":"149","article-title":"Butyrate emerges as a crucial effector of Zhi-Zi-Chi decoctions to ameliorate depression via multiple pathways of brain-gut axis","volume":"1","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bbi.2025.106237_b0380","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1017\/neu.2017.33","article-title":"Failure to detect the action of antidepressants in the forced swim test in swiss mice","volume":"30","author":"Suman","year":"2018","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbi.2025.106237_b0385","article-title":"The Gut Microbiota Metabolite Butyrate Modulates Acute Stress-Induced Ferroptosis in the Prefrontal Cortex via the Gut\u2013Brain Axis","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.106237_b0390","doi-asserted-by":"crossref","unstructured":"Leo A, De Caro C, Mainardi P, Tallarico M, Nesci V, Marascio N, et al. Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression. Neuropharmacology [Internet]. 2021;198(July):108782. Available from: https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108782.","DOI":"10.1016\/j.neuropharm.2021.108782"},{"key":"10.1016\/j.bbi.2025.106237_b0395","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/srep08171","article-title":"An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine","volume":"5","author":"Schmauss","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.106237_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109660","article-title":"Sodium propionate oral supplementation ameliorates depressive-like behavior through gut microbiome and histone 3 epigenetic regulation","author":"Behrens","year":"2024","journal-title":"J. Nutr. Biochem."},{"issue":"165","key":"10.1016\/j.bbi.2025.106237_b0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainresbull.2020.09.014","article-title":"Long-lasting effects of postweaning sodium butyrate exposure on social behaviors in adult mice","volume":"1","author":"Zhao","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2025.106237_b0410","doi-asserted-by":"crossref","unstructured":"Mishra SP, Jain S, Wang B, Wang S, Miller BC, Lee JY, et al. Abnormalities in microbiota\/butyrate\/ FFAR3 signaling in aging gut impair brain function. JCI Insight [Internet]. 2024;9(3):e168443. Available from: https:\/\/doi.org\/10.1172\/jci.","DOI":"10.1172\/jci.insight.168443"},{"key":"10.1016\/j.bbi.2025.106237_b0415","first-page":"908","article-title":"Gut commensal-derived butyrate reverses obesity-induced social deficits and anxiety-like behaviors via regulation of microglial homeostasis","volume":"5","author":"Duan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbi.2025.106237_b0420","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s11064-021-03368-0","article-title":"Histone Deacetylase 2-Mediated Epigenetic Regulation is involved in the Early Isoflurane Exposure-Related increase in Susceptibility to Anxiety-like Behaviour Evoked by Chronic Variable stress in mice","volume":"46","author":"Peng","year":"2021","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.bbi.2025.106237_b0425","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/npp.2014.73","article-title":"Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior","volume":"39","author":"Sarkar","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.106237_b0430","doi-asserted-by":"crossref","unstructured":"Zhang M, Li RW, Yang H, Tan Z, Liu F. Recent advances in developing butyrogenic functional foods to promote gut health. Crit Rev Food Sci Nutr [Internet]. 2022;13(64):4410\u201331. Available from: https:\/\/doi.org\/10.1080\/10408398.2022.2142194.","DOI":"10.1080\/10408398.2022.2142194"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/1886.2021.00001","article-title":"A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections","volume":"11","author":"Du","year":"2021","journal-title":"Eur J Microbiol Immunol (bp)."},{"issue":"8","key":"10.1016\/j.bbi.2025.106237_b0440","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/nmo.12378","article-title":"Correlation between the human fecal microbiota and depression","volume":"26","author":"Naseribafrouei","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bbi.2025.106237_b0445","doi-asserted-by":"crossref","unstructured":"Jiang H yin, Zhang X, Yu Z he, Zhang Z, Deng M, Zhao J hua, et al. Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res [Internet]. 2018;104(March):130\u20136. Available from: https:\/\/doi.org\/10.1016\/j.jpsychires.2018.07.007.","DOI":"10.1016\/j.jpsychires.2018.07.007"},{"key":"10.1016\/j.bbi.2025.106237_b0450","doi-asserted-by":"crossref","unstructured":"Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, et al. Gut microbiota in Parkinson\u2019s disease: Temporal stability and relations to disease progression. EBioMedicine [Internet]. 2019;44:691\u2013707. Available from: https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.064.","DOI":"10.1016\/j.ebiom.2019.05.064"},{"key":"10.1016\/j.bbi.2025.106237_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00392","article-title":"Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders","author":"Kelly","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2025.106237_b0460","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-129","article-title":"Understanding the somatic consequences of depression: Biological mechanisms and the role of depression symptom profile","author":"Penninx","year":"2013","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.bbi.2025.106237_b0465","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2017-314759","article-title":"Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression","volume":"67","author":"Stevens","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbi.2025.106237_b0470","first-page":"117","article-title":"The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuroendocrinol. Lett."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2012.02.023","article-title":"Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut","volume":"141","author":"Maes","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12978","article-title":"Leaky gut biomarkers in depression and suicidal behavior","volume":"139","author":"Ohlsson","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0485","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12640-019-00126-7","article-title":"Increased Serum Immunoglobulin responses to Gut Commensal Gram-negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, especially when Melancholia is present","volume":"37","author":"Simeonova","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbi.2025.106237_b0490","doi-asserted-by":"crossref","unstructured":"Calarge CA, Devaraj S, Shulman RJ. Gut permeability and depressive symptom severity in unmedicated adolescents. J Affect Disord [Internet]. 2019;246(September 2018):586\u201394. Available from: https:\/\/doi.org\/10.1016\/j.jad.2018.12.077.","DOI":"10.1016\/j.jad.2018.12.077"},{"key":"10.1016\/j.bbi.2025.106237_b0495","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbi.2014.03.020","article-title":"Expression of Toll-like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder","volume":"40","author":"K\u00e9ri","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","article-title":"Intestinal barrier function: Molecular regulation and disease pathogenesis","volume":"124","author":"Groschwitz","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbi.2025.106237_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/S1567-7443(07)00201-3","article-title":"Axis and the Immune System. a Perspective","volume":"7(C):3\u201315","author":"Dunn","year":"2007","journal-title":"NeuroImmune Biology."},{"issue":"79","key":"10.1016\/j.bbi.2025.106237_b0510","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","article-title":"Microglia in Physiology and Disease","volume":"10","author":"Wolf","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"87","key":"10.1016\/j.bbi.2025.106237_b0515","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"1","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.106237_b0520","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02492-0","article-title":"Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression","author":"Wang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.106237_b0525","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.copsyc.2014.12.024","article-title":"Stress and depression: Old questions, new approaches","volume":"4","author":"Hammen","year":"2015","journal-title":"Curr. Opin. Psychol."},{"key":"10.1016\/j.bbi.2025.106237_b0530","doi-asserted-by":"crossref","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","article-title":"Inhibition of histone deacetylase activity by butyrate","volume":"133","author":"Davie","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbi.2025.106237_b0535","first-page":"179","article-title":"Histone deacetylases and their inhibitors in inflammatory diseases","volume":"1","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bbi.2025.106237_b0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031172","article-title":"How Microbes Affect Depression: underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics","volume":"23","author":"Suda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.106237_b0545","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7571-6_1","article-title":"Neurotrophic factors: an overview","author":"Skaper","year":"2018"},{"issue":"8","key":"10.1016\/j.bbi.2025.106237_b0550","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2025.106237_b0555","first-page":"15","article-title":"Blood Brain-Derived Neurotrophic factor (BDNF) and Major Depression: do we have a Translational Perspective?","volume":"12","author":"Arosio","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2025.106237_b0560","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","article-title":"Depression Heterogeneity and its Biological Underpinnings: Toward Immunometabolic Depression","volume":"88","author":"Milaneschi","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106237_b0565","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/asj.13118","article-title":"Pitfalls in short-chain fatty acid research: a methodological review","volume":"90","author":"Sakata","year":"2019","journal-title":"Animal Science Journal. Blackwell Publishing"},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37246-7","article-title":"Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males","volume":"9","author":"Cleophas","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbi.2025.106237_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41424-018-0025-4","article-title":"Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects article","volume":"9","author":"Bouter","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bbi.2025.106237_b0580","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/nmo.13914","article-title":"Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease","volume":"32","author":"Facchin","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"9","key":"10.1016\/j.bbi.2025.106237_b0585","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2005.02639.x","article-title":"Oral butyrate for mildly to moderately active Crohn\u2019s disease","volume":"22","author":"Di Sabatino","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bbi.2025.106237_b0590","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1023\/A:1005537411244","article-title":"Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: Randomized, double-blind, placebo- controlled pilot study","volume":"45","author":"Vernia","year":"2000","journal-title":"Dig. Dis. Sci."},{"issue":"3283","key":"10.1016\/j.bbi.2025.106237_b0595","article-title":"Sodium butyrate effectiveness in children and adolescents with newly diagnosed inflammatory bowel diseases\u2014randomized placebo-controlled multicenter trial","volume":"14","author":"Pietrzak","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.bbi.2025.106237_b0600","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1463-1318.2012.03152.x","article-title":"Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome","volume":"15","author":"Banasiewicz","year":"2013","journal-title":"Colorectal Dis."},{"issue":"1","key":"10.1016\/j.bbi.2025.106237_b0605","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5114\/pg.2021.112681","article-title":"The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome","volume":"17","author":"Lewandowski","year":"2022","journal-title":"Gastroenterology Review."},{"issue":"3","key":"10.1016\/j.bbi.2025.106237_b0610","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291715002044","article-title":"Depression as a systemic syndrome: Mapping the feedback loops of major depressive disorder","volume":"46","author":"Wittenborn","year":"2016","journal-title":"Psychol. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125004799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125004799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:13:24Z","timestamp":1768954404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125004799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":122,"alternative-id":["S0889159125004799"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106237","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From gut to glee: Is butyrate a promising antidepressant? A systematic review and mechanistic insights","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106237"}}